The Copenhagen Triage Algorithm

Triage Clinical Trial

— CTA  

Official title:

The Copenhagen Triage Algorithm

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02698319
• Other study ID #: HerlevH02
• Status: Completed
• Phase: N/A
• First received: February 24, 2016
• Last updated: August 15, 2016
• Start date: April 2015
• Est. completion date: June 2016

Study information

• Verified date: August 2016
• Source: Herlev Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Danish Health AuthorityDenmark: The Danish Data Protection Agency
• Study type: Interventional

Clinical Trial Summary

Crowding in the emergency department (ED) is a well documented problem putting patients at risk of adverse outcomes. To combat this, most ED's use some form of triage. In the last two decades systematic triage or process triage has become the norm in most countries but this approach is supported by limited evidence. Our aim is to develop a faster triage model of only a few vital parameters, based on a data from a large cohort of unselected ED patients and evaluate if such a model combined with a clinical assessment by the ED nurse is inferior to existing triage models in a prospective cluster-randomized trial

Recruitment information / eligibility

• Status: Completed
• Enrollment: 50000
• Est. completion date: June 2016
• Est. primary completion date: April 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 16 Years and older

Eligibility

Inclusion Criteria:

• Patients presenting acutely to the Acute ward/Emergency department in two hospitals in the Capital of Denmark

Exclusion Criteria:

• Patients presenting in Pediatric, Gynecological or Obstetric units

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Triage

Intervention

Behavioral:
• Copenhagen Triage Algorithm
The Copenhagen Triage Algorithm is a new triage method for faster triage in the ED

Locations

Country	Name	City	State
Denmark	Herlev Hospital	Herlev	Region Hovedstaden
Denmark	Bispebjerg Hospital	København NV	Region Hovedstaden

Sponsors (1)

Lead Sponsor	Collaborator
Herlev Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	All cause mortality	Time frame starts at the beginning of the index admission, defined as first admission in the study period. Patients will be followed using central registers.	30 days	No
Secondary	Number of patients with an admission to the intensive care unit		30 days	No
Secondary	Length of stay during admission		30 days	No
Secondary	Waiting time for treatment	Waiting time from first presenting at ED to first treatment startet	8 hours	No
Secondary	Number of readmissions	Patients will be followed using central registers. All new admissions within 91 days of the same patient is defined as readmissions.	30 and 90 days	No
Secondary	All cause mortality		48 hours	No
Secondary	All cause mortality		90 days	No